PharmaNutra SpA (MIL:PHN) Moat Score: 0/10 (As of Jul. 02, 2026)


MIL:PHN PharmaNutra SpA MIL:PHN
87 GF Score
Price €87.30
GF Value €71.57
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is PharmaNutra SpA Moat Score?

PharmaNutra SpA has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

PharmaNutra SpA has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes PharmaNutra SpA might have No Moat - No discernible moat.

PharmaNutra SpA  (MIL:PHN) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

PharmaNutra SpA Moat Score Related Terms

MIL:PHN
87GF Score
PharmaNutra SpA MIL:PHN
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PharmaNutra SpA (MIL:PHN) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaNutra SpA stock appears to be overvalued. The current stock price of €87.30 is trading 22% above its estimated GF Value™ of €71.57. GuruFocus considers PharmaNutra SpA to be Modestly Overvalued.

Key valuation signals for MIL:PHN:

  • Moat Score: 0
  • GF Value™: €71.57 vs. price of €87.30 (22% above fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the MIL:PHN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PharmaNutra SpA Business Description

Other Exchanges PHNm:UK761:Germany
Address Via Campodavela 1, Pisa, ITA, 56122
PharmaNutra SpA is a pharmaceutical company. The company is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. The products of the company include SiderAL Folic, UltraMag, Cetilar, and others. The company operates in Europe, the Middle East, South America, the Far East, and other regions.
87GF Score

Get the complete analysis for MIL:PHN

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€87.30
Price
€71.57
GF Value